News Center
Longcharm Analysis Laboratory passed the first FDA remote audit with zero defects
ZHEJIANG / LONGCHARM / BIO-TECH PHARMA. / Co., Ltd.
Differentiated Innovative Drug Research Unique Translational Platform Technology
See more
News Center
The first double reporting BE project undertaken by Longcharm passed FDA remote inspection
News Center
Congratulate Longcharm on successful relocation
News Center
"Heart to heart integration and win-win cooperation" Longcharm and Yibai Health signed a strategic cooperation agreement
Our Mission
Committed to building a highly differentiated project system through core technologies such as special administration routes and nucleic acid delivery systems. Establish a complete new drug industry platform from preclinical discovery to clinical development and industrialization
Watch video
Product Pipeline
We have deployed two clinical-stage innovative drugs in the field of oncology. At the same time, we have improved drug targeting and changed drug efficacy and toxicity through ADME improvement and nucleic acid delivery technology.
Development Course
The predecessor, Hangzhou Biyitai Medical Technology Co., Ltd., passed the inter-laboratory quality assessment of the Ministry of Health in 2019
Partner
Adhering to the cooperation concept of "accelerating the transformation of R&D projects into industry, realizing the drug listing for the benefit of patients", we have established project cooperation relationships with many universities and enterprises
Service Items
Covering the whole process of drug research and development, from raw material technology, quality control, pharmacological efficacy research, toxicological safety evaluation, preclinical PK analysis, generic drug consistency evaluation and clinical approval development, etc.
@2022. all rights reserved
About us
